49 / 64
AFRICA
S47
CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015
Global Burden of Diseases, Injuries and Risk Factors 2010 Study.
Prog
Cardiovasc Dis
2013;
56
(3): 234–239.
19. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular
diseases: part I: general considerations, the epidemiologic transition,
risk factors, and impact of urbanization.
Circulation
2001;
104
(22):
2746–2753.
20. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular
diseases: Part II: variations in cardiovascular disease by specific ethnic
groups and geographic regions and prevention strategies.
Circulation
2001;
104
(23): 2855–2864.
21. Khedr EM,
et al
. Epidemiological study and risk factors of stroke in
Assiut Governorate, Egypt: community-based study.
Neuroepidemiology
2013;
40
(4): 288–294.
22. Akinyemi RO, Izzeldin IM, Dotchin C, Gray WK, Adeniji O, Seidi OA,
et al
. Contribution of noncommunicable diseases to medical admis-
sions of elderly adults in Africa: a prospective, cross-sectional study in
Nigeria, Sudan, and Tanzania.
J Am Geriatr Soc
2014;
62
(8): 1460–1466.
23. Owolabi LF, Shehu MY, Shehu MN, Fadare J. Pattern of neurological
admissions in the tropics: Experience at Kano, Northwestern Nigeria
.
Ann Indian Acad Neurol
2010;
13
(3): 167–170.
24. Akinyemi RO, Allan L, Owolabi MO, Akinyemi JO, Ogbole G, Ajani
A et al. Profile and determinants of vascular cognitive impairment in
African stroke survivors: The CogFAST Nigeria Study
.
J Neurol Sci
2014;
346
(1–2): 241–249.
25. Akinyemi RO, Mukaetova-Ladinska EB, Attems J, Ihara M, Kalaria
RN. Vascular risk factors and neurodegeneration in ageing related
dementias: Alzheimer’s disease and vascular dementia
. Curr Alzheimer
Res
2013;
10
(6): 642–53.
26. Owolabi MO. Impact of stroke on health-related quality of life in
diverse cultures: the Berlin–Ibadan multicenter international study.
Health Qual Life Outcomes
2011;
9
: 81.
27. O’Donnell MJ. Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P,
et
al
. Risk factors for ischaemic and intracerebral haemorrhagic stroke in
22 countries (the INTERSTROKE study): a case-control study.
Lancet
2010;
376
(9735): 112–123.
28. Adeloye D, Basquill C. Estimating the prevalence and awareness rates
of hypertension in Africa: a systematic analysis.
PLoS One
2014;
9
(8):
e104300.
29. Howard VJ, Kleindorfer DO, Judd SE, McClure LA, Safford MM,
Rhodes JD,
et al
. Disparities in stroke incidence contributing to dispari-
ties in stroke mortality.
Ann Neurol
2011;
69
(4): 619–627.
30. Gutierrez J, Williams OA. A decade of racial and ethnic stroke dispari-
ties in the United States.
Neurology
2014;
82
(12): 1080–1082.
31. Douiri A, Rudd AG, Wolfe CD. Prevalence of poststroke cognitive
impairment: South London Stroke Register 1995–2010.
Stroke
2013;
44
(1): 138–145.
32. Rotimi CN, Jorde LB. Ancestry and disease in the age of genomic medi-
cine.
N Engl J Med
2010;
363
(16): 1551–1558.
33. Saab KR, Kendrick J, Yracheta JM, Lanaspa MA, Pollard M, Johnson
RJ. New insights on the risk for cardiovascular disease in African
Americans: The role of added sugars
.
J Am Soc Nephrol
2015;
26
(2):
247–257.
34. Burchard EG, Ziv E, Coyle N, Gomez SL,Tang H, Karter AJ,
et al
. The
importance of race and ethnic background in biomedical research and
clinical practice
. N Engl J Med
2003;
348
(12): 1170–1175.
35. Collins FS.
W
hat we do and don’t know about ‘race’, ‘ethnicity’, genet-
ics and health at the dawn of the genome era.
Nat Genet
2004;
36
(Suppl
11): S13–15.
36. Cooper RS, Kaufman JS, Ward R, Race and genomics.
N Engl J Med
2003;
348
(12): 1166–1170.
37. Adeyemo AA, Chen G, Chen Y, Rotimi C. Genetic structure in four
West African population groups.
BMC Genet
2005.
6
: 38.
38. Ramsay M, Tiemessen CT, Choudhury A, Soodyall H. Africa: the
next frontier for human disease gene discovery?
Hum Mol Genet
2011;
20
(R2): R214–220.
39. Gomez F, Hirbo J, Tishkoff SA. Genetic variation and adaptation in
Africa: implications for human evolution and disease.
Cold Spring Harb
Perspect Biol
2014;
6
(7): a008524.
40. International HapMap Consortium. A second generation human haplo-
type map of over 3.1 million SNPs.
Nature
2007;
449
(7164): 851–861.
41. Genomes Project Consortium. An integrated map of genetic variation
from 1,092 human genomes.
Nature
2012;
491
(7422): 56–65.
42. Graffe CC, Bech JN, Lauridsen TG, Vase H, Pedersen EB. Abnormal
increase in urinary aquaporin-2 excretion in response to hypertonic
saline in essential hypertension.
BMC Nephrol
2012;
13
: 15.
43. Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN,
Lichtenauer UD,
et al
. Somatic mutations in ATP1A1 and ATP2B3 lead
to aldosterone-producing adenomas and secondary hypertension
. Nat
Genet
2013;
45
(4): 440–4, 444e1–2.
44. Bryc K, Auton A, Nelson MR, Oksenberg JR, Hauser SL, Williams S,
et al
. Genome-wide patterns of population structure and admixture in
West Africans and African Americans.
Proc Natl Acad Sci USA
2010;
107
(2): 786–791.
45. Bryc K, Durand EY, Macpherson JM, Reich D, Mountain JL.
The Genetic Ancestry of African Americans, Latinos, and European
Americans across the United States
.
Am J Hum Genet
2015;
96
(1):
37–53.
46. Dichgans M. Genetics of ischaemic stroke.
Lancet Neurol
2007;
6
(2):
149–161.
47. Morrison AC, Fornage M, Liao D, Boerwinkle E. Parental history of
stroke predicts subclinical but not clinical stroke: the Atherosclerosis
Risk in Communities Study.
Stroke
2000;
31
(9): 2098–2102.
48. Liao D, Myers R, Hunt S, Shahar E, Paton C, Burke G,
et al
. Familial
history of stroke and stroke risk. The Family Heart Study.
Stroke
1997;
28
(10): 1908–1912.
49. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods
and results of studies of the genetic epidemiology of ischemic stroke
.
Stroke
2004;
35
(1): 212–227.
50. Minor DS, Wofford MR, Jones DW. Racial and ethnic differences in
hypertension.
Curr Atheroscler Rep
2008;
10
(2): 121–127.
51. Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, Huang H,
et
al.
A genome-wide association study of hypertension and blood pressure
in African Americans.
PLoS Genet
2009;
5
(7): e1000564.
52. Reder NP, Tayo BO, Salako B, Ogunniyi A, Adeyemo A, Rotimi C,
et
al.
Adrenergic alpha-1 pathway is associated with hypertension among
Nigerians in a pathway-focused analysis
. PLoS One
2012;
7
(5): e37145.
53. Rice T, Cooper RS, Wu X, Bouchard C, Rankinen T, Rao DC,
et al.
Meta-analysis of genome-wide scans for blood pressure in African
American and Nigerian samples. The National Heart, Lung, and Blood
Institute GeneLink Project.
Am J Hypertens
2006;
19
(3): 270–274.
54. Sorensen IF, Vazquez AI, Irvin MR, Sorensen P, Davis BR, Ford CE,
et al.
Pharmacogenetic effects of ‘candidate gene complexes’ on stroke
in the GenHAT study.
Pharmacogenet Genomics
2014;
24
(11): 556–563.
55. Adeleye JO, Abbiyesuku FM. Glucose and insulin responses in offspring
of Nigerian Type 2 diabetics.
Afr J Med Med Sci
2002;
31
(3): 253–257.
56. Mbanya JC, Pani LN, Mbanya DN, Sobngwi E, Ngogang J,
et al.
Reduced insulin secretion in offspring of African type 2 diabetic parents.
Diabetes Care
2000;
23
(12): 1761–1765.
57. Tekola-Ayele F, Adeyemo AA, Rotimi CN. Genetic epidemiology of
type 2 diabetes and cardiovascular diseases in Africa.
Prog Cardiovasc